feedback

Provider Statement

This continuing medical education activity is provided by

Support Statement

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Activity Chair

Paul E. Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, MA

Disclosures
Consulting Fee: AbbVie, Bristol-Myers Squibb, GlaxoSmithKline/ViiV, Gilead, Janssen, Merck
Contracted Research (paid to institution): Bristol-Myers Squibb, GlaxoSmithKline/ViiV, Gilead, Merck


Faculty

Joseph J. Eron, Jr., MD
Professor of Medicine
Division of Infectious Diseases
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, NC

Disclosures
Consulting Fee: AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck, ViiV
Contracted Research (paid to institution): Bristol-Myers Squibb, Gilead, Janssen, ViiV


Charles Hicks, MD
Professor of Medicine
Director
Owen Clinic
University of California
San Diego, CA

Disclosures
Royalty: UpToDate, Inc.
Consulting Fee: Bristol-Myers Squibb, Gilead, Janssen, Merck, ViiV


Grace A. McComsey, MD, FIDSA
Kennell Endowed Chair
Professor of Pediatrics and Medicine
Director, Dahms Clinical Research Unit
Chief, Pediatric Infectious Diseases and Rheumatology
Case Western Reserve University
University Hospitals Case Medical Center
Cleveland, OH

Disclosures
Consulting Fee: Bristol-Myers Squibb, Gilead, ICON, ViiV


Susanna Naggie, MD, MHS
Associate Professor of Medicine
Duke University School of Medicine
Division of Infectious Diseases
Duke Clinical Research Institute
Durham Veterans Affairs Medical Center
Durham, NC

Disclosures
Contracted Research: AbbVie, Bristol-Myers Squibb, BTG International, Inc., Gilead Sciences, Janssen, Merck, Tacere


External Reviewer

Rebecca Clark, MD has no relevant financial relationships to disclose.

Vindico Medical Education staff have no relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears above.

Activity Details

Credit Type: AMA PRA Category 1 Credit
Credit Amount: 1.0 AMA PRA Category 1 Credit
Release Date: August 23, 2016
Expiration Date: August 23, 2017
Estimated Time to Complete Activity: 1 hour
Registration Required: No
Fee for Activity: There is no fee for participating in this activity.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, August 23, 2016 to August 23, 2017.

How To Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete and return the registration form and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Overview

With the rapid advances in HIV management, health care providers need to remain informed about guideline changes, developments in antiretroviral therapy, as well as special issues for patients with concurrent infections and comorbidities. In this activity, Optimizing Long-term Outcomes for Patients with HIV: A Virtual Patient Clinic, 4 different patients will be presented, each with unique challenges. As you manage each patient, you will receive feedback and expert commentary offered by faculty discussing various aspects of HIV management. Topics include treatment regimens for the newly diagnosed patient, selecting HIV therapy based on individual patient characteristics, preferences, age-related comorbidities, and/or coinfection, as well as implementing effective switching strategies for HIV management.

Target Audience

The intended audience for the activity is infectious disease specialists, primary care physicians, internal medicine physicians, and other health care professionals involved in the treatment of patients with HIV.

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Examine current treatment guidelines and the clinical safety and efficacy of newly approved HIV therapies.
  • Implement HIV treatment regimens for newly diagnosed patients that maximize efficacy and tolerability for improved long-term outcomes.
  • Select HIV therapy that reflects individual patient characteristics, preferences, age-related comorbidities, and/or coinfection as a means to optimize long-term outcomes.
  • Employ effective HIV switching strategies that maximize efficacy and tolerability for improved long-term outcomes.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at CME@VindicoCME.com

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.